MYCOPLASMAL INFECTION - TOPICAL ISSUE IN PEDIATRICS


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Рұқсат ақылы немесе тек жазылушылар үшін

Аннотация

The article discusses the problem of mycoplasmal infection in pediatric practice. Mycoplasma pneumoniae is a fairly common agent of acute respiratory infections in children, which is the second most important etiologic factor in the development of community-acquired pneumonia in children older than 5 years. Mycoplasmal infection can occur in different clinical variants with varying degrees of severity, and the severity of the course and the spectrum of clinical manifestations, both respiratory and non-respiratory, are associated most with the virulence of the pathogen and the immune potential of the infected person. There is still a need to develop an readily accessible test for rapid diagnosis. Antibacterial therapy is recommended for the treatment of pneumonia and severe forms requiring hospitalization.

Толық мәтін

Рұқсат жабық

Авторлар туралы

M. Khadisova

Moscow Regional Scientific Research Clinical Institute n.a. M.F. Vladimirsky

Email: murzabekova.marina.1979@mail.ru
PhD, Researcher at the Department of Children’s Infectious Diseases

Әдебиет тізімі

  1. Самсыгина Г.А. Микоплазмоз респираторного тракта у детей и подростков. Consiüium Medicum. Педиатрия (Приложение). 2011;4:67-70.
  2. Yamazaki T., Kenri T. Epidemiology of Mycoplasma pneumoniae Infections in Japan and Therapeutic Strategies for Macrolide-Resistant M. pneumoniae. Front. Microbiol. 2016;7:693. Doi: 10.3389/ fmicb.2016.00693.
  3. Sun H., Xue G., Yan C., et al. Changes in Molecular Characteristics of Mycoplasma pneumoniae in Clinical Specimens from Children in Beijing between 2003 and 2015. PLoS One. 2017;12(1):e0170253. doi: 10.1371/journal. pone.0170253.
  4. Liao J.Y., Zhang T. Distribution characteristics of Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella pneumophila in hospitalized children with acute respiratory tract infection: an analysis of 13 198 cases. Zhongguo Dang Dai Er Ke Za Zhi. 2016;18(7):607-13.
  5. Хадисова М.К. Клинико-лабораторные особенности, вопросы терапии микоплазменной инфекции (Mycoplasma pneumoniae) у детей с острыми респираторными заболеваниями. Дисс. канд. мед. наук. 2013.
  6. Королева Е.Г., Осидак Л.В., Милькинт К.К. и др. Респираторная микоплазменная инфекция у детей с отягощенным преморбидным фоном. Детские инфекции. 2004:4:17-22.
  7. Narita M. Pathogenesis of extrapulmonary manifestations of Mycoplasma pneumoniae infection with special reference to pneumonia. J. Infect. Chemother. 2010;16:162-69. doi: 10.1007/s10156-010-0044-x.
  8. Харламова Ф.С., Шамшева О.В., Воробьева Д.А. и др. Микоплазменная инфекция у детей: современная диагностика и терапия. Детские инфекции. 2016;15(3):50-7. Doi: 10.1234/ XXXX-XXXX-2016-3-50-57.
  9. Izumikawa K. Clinical Features of Severe or Fatal Mycoplasma pneumoniae Pneumonia. Front. Microbiol. 2016;7:800. Doi: 10.3389/ fmicb.2016.00800.
  10. Saraya T., Nakata K., Nakagaki K., et al. Identification of a mechanism for lung inflammation caused by Mycoplasma pneumoniae using a novel mouse model. Results Immunol. 2011;1(1):76-87. doi: 10.1016/j.rinim.2011.11.001.
  11. Chaudhry R., Ghosh A., Chandolia A. Pathogenesis of Mycoplasma pneumoniae: An update. Ind. J. Med. Microbiol. 2016;34(1):7-16. doi: 10.4103/0255-0857.174112. Review.
  12. Techasaensiri C., Tagliabue C., Cagle M., et al. Variation in colonization, ADP-ribosylating and vacuolating cytotoxin, and pulmonary disease severity among mycoplasma pneumoniae strains. Am. J. Respir. Crit. Care Med. 2010;182(6):797-804. doi: 10.1164/rccm.201001-00800C.
  13. Jiang W., Yan Y., Ji W., et al. Clinical significance of different bacterial load of Mycoplasma pneumoniae in patients with Mycoplasma pneumoniae pneumonia. Braz. J. Infect. Dis. 2014;18:124-28. doi: 10.1016/j.bjid.2013.06.004.
  14. Внебольничная пневмония у детей. Клинические рекомендации. Российское респираторное общество. Межрегиональное педиатрическое респираторное общество. Федерация педиатров стран СНГ. Московское общество детских врачей. М., 2015. 64 с.
  15. Савенкова М.С., Савенков М.П., Самитова Э.Р. и др. Микоплазменная инфекция: клинические формы, особенности течения, ошибки диагностики. Вопросы современной педиатрии. 2013;12(6):108-14.
  16. Bajantri B., Venkatram S., Diaz-Fuentes G. Mycoplasma pneumoniae: A Potentially Severe Infection. J. Clin. Med. Res. 2018;10(7):535-44. doi: 10.14740/jocmr3421w.
  17. Nilsson A.C., Bjorkman P., Persson K. Polymerase chain reaction is superior to serology for the diagnosis of acute Mycoplasma pneumoniae infection and reveals a high rate of persistent infection. BMC. Microbiol. 2008;8:93.
  18. Lee W.J., Huang E.Y., Tsai C.M., et al. Role of Serum Mycoplasma pneumoniae IgA, IgM, and IgG in the Diagnosis of Mycoplasma pneumoniae-Related Pneumonia in School-Age Children and Adolescents. Clin. Vaccine Immunol. 2017;24(1):e00471-16. doi: 10.1128/CVI.00471-16.
  19. Spuesens E.B., Fraaij P.L., Visser E.G., et al. Carriage of Mycoplasma pneumoniae in the upper respiratory tract of symptomatic and asymptomatic children: an observational study. PLoS Med. 2013;10(5):e1001444. doi: 10.1371/journal. pmed.1001444.
  20. Pereyre S., Goret J., Bébéar C. Mycoplasma pneumoniae: Current Knowledge on Macrolide Resistance and Treatment. Front Microbiol. 2016;7:974. doi: 10.3389/fmicb. 2016.00974.

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу

© Bionika Media, 2018

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>